The DOI matches its Crossref record; 110 of the 114 references it cites were found in a registry or an index.
The Dual Roles of NRF2 in Cancer
Open accessAbstract
NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress. However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy. In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NRF2 is mutationally activated in 10–30% of different solid tumors including liver, lung, stomach, colon and other cancers and mutations typically disrupt the interaction between NRF2 and its E3 ligase KEAP1 (Kelch Like ECH Associated Protein 1) directly or by impeding KEAP1 co-factors CUL3 (Cullin 3) and CAND1 (Cullin Associated and Neddylation Dissociated 1) [2,5,6,7,8].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [8]
In the citing paper
“NRF2 is mutationally activated in 10–30% of different solid tumors including liver, lung, stomach, colon and other cancers and mutations typically disrupt the interaction between NRF2 and its E3 ligase KEAP1 (Kelch Like ECH Associated Protein 1) directly or by impeding KEAP1 co-factors CUL3 (Cullin 3) and CAND1 (Cullin Associated and Neddylation Dissociated 1) [2,5,6,7,8].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [8]
In the citing paper
“In this regard, mutations to NRF2 and its regulator KEAP1 have been found in cancer cells, supporting the supposition that antioxidant genes are pivotal in tumor progression59–62.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [61]
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“NRF2: Tumor Suppressor or Oncogene? The main function of the transcription factor NRF2 [also known as NFE2L2, nuclear factor (erythroid-derived-2)-like 2] is to activate the cellular antioxidant response by inducing the transcription of several genes to protect cells from the effects of exogenous and endogenous insult…”
BackgroundMoi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Benmaad, I., Caldéraro, J., Bioulac‐Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,522
Flagged first, then by citations
4 of the 114 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 637
Ravasz, D., Kacsó, G., Fodor, V., Horvath, K., Ádám‐Vizi, V., & Chinopoulos, C. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.05.002 · Cited by 15
Free heme regulates placenta growth factor through NRF2-antioxidant response signaling
Kapetanaki, M. G., Gbotosho, O. T., Sharma, D., Weidert, F. L., Ofori-Acquah, S. F., & Kato, G. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.08.009 · Cited by 15
The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas
Gatti, V., Bernassola, F., Talora, C., Melino, G., & Peschiaroli, A. (2020) · Cancers · doi:10.3390/cancers12061595 · Cited by 15
Fabrizio, F. P., Mazza, T., Castellana, S., Sparaneo, A., & Muscarella, L. A. (2020) · Antioxidants · doi:10.3390/antiox9090904 · Cited by 15
Aborehab, N. M., & Waly, N. E. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.05.008 · Cited by 14
Nrf2-Mediated Antioxidant Defense and Thyroid Hormone Signaling: A Focus on Cardioprotective Effects
Sabatino, L. (2023) · Antioxidants · doi:10.3390/antiox12061177 · Cited by 21
The bridge between cell survival and cell death: reactive oxygen species-mediated cellular stress
Acar, N. V., & Özgül, R. K. (2023) · EXCLI journal · doi:10.17179/excli2023-6221 · Cited by 19
Bae, T., & Kwak, M. (2024) · Journal of Cancer Prevention · doi:10.15430/jcp.24.021 · Cited by 15
Characterization of cancer omics and drug perturbations in panels of lung cancer cells
Suzuki, A., Onodera, K., Matsui, K., Seki, M., Esumi, H., Soga, T., Sugano, S., Kohno, T., Suzuki, Y., & Tsuchihara, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-55692-9 · Cited by 15
Xiong, Q., Tian, X., Li, W., Chen, L., Zhou, M., Xu, C., & Ru, Q. (2020) · Food and Agricultural Immunology · doi:10.1080/09540105.2020.1784099 · Cited by 14
Nrf2 activation contributes to hepatic tumor-augmenting effects of developmental arsenic exposure
Wu, R., Chen, X., Wu, H., Hu, Y., Wang, G., Wang, H., Yang, B., Fu, J., Gao, Y., Pi, J., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155685 · Cited by 14
Regulation of VEGFA, KRAS, and NFE2L2 Oncogenes by MicroRNAs in Head and Neck Cancer
Cuzziol, C. I., Marzochi, L. L., Possebon, V. S., Kawasaki‐Oyama, R. S., Mattos, M. F., Serafim, V., Ferreira, L. A. M., Pavarino, É. C., Castanhole-Nunes, M. M. U., & Goloni‐Bertollo, E. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137483 · Cited by 14
Skowron, M. A., Niegisch, G., Albrecht, P., van Koeveringe, G. A., Romano, A., Albers, P., Schulz, W. A., & Hoffmann, M. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081680 · Cited by 14
Abo‐Youssef, A. M., Khalaf, M. M., Malak, M. N., & Hamzawy, M. A. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab049 · Cited by 14
The Effects of Ginsenosides on the Nrf2 Signaling Pathway
Ashrafizadeh, M., Ahmadi, Z., Yaribeygi, H., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73234-9_20 · Cited by 13
Soutto, M., Zhang, X., Bhat, N. S., Chen, Z., Zhu, S., Maacha, S., Genoula, M., El-Gazzaz, O., Peng, D., Lu, H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102998 · Cited by 13
Nitro-fatty acids: promising agents for the development of new cancer therapeutics
Roos, J., Manolikakes, G., Schlomann, U., Klinke, A., Schopfer, F. J., Neumann, C. A., & Maier, T. J. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.09.009 · Cited by 13
Gao, J., Li, A., Xu, Y., & Huang, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.911902 · Cited by 13
Yabaji, S. M., Mishra, A., Chatterjee, A., Dubey, R. K., Srivastava, K., & Srivastava, K. K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.055 · Cited by 13
Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice
Tan, M. W. Y., Sng, M. K., Cheng, H. S., Low, Z. S., Leong, B. J. J., Chua, D., Tan, E. H. P., Chan, J. S. K., Yip, Y. S., Lee, Y. H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0535-y · Cited by 13
Low Ozone Concentrations Affect the Structural and Functional Features of Jurkat T Cells
Cappellozza, E., Costanzo, M., Calderan, L., Galiè, M., Angelini, O., Tabaracci, G., & Malatesta, M. (2021) · Processes · doi:10.3390/pr9061030 · Cited by 13
Kumar, A., & Ramanarayanan, S. (2025) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2025-0153 · Cited by 12
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes
Kowalik, M. A., Taguchi, K., Serra, M., Caddeo, A. M., Puliga, E., Bacci, M., Koshiba, S., Inoue, J., Hishinuma, E., Morandi, A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000568 · Cited by 12
Self-citationRedox and metabolic reprogramming in breast cancer and cancer‐associated adipose tissue
Zakić, T., Pekovic‐Vaughan, V., Čvoro, A., Korać, A., Janković, A., & Korać, B. (2023) · FEBS Letters · doi:10.1002/1873-3468.14794 · Cited by 15
Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review
Fakhrioliaei, A., Tanhaei, S., Pakmehr, S., Shakir, M. N., Qasim, M. T., Hariri, M., Kararoudi, A. N., & Valilo, M. (2024) · The Journal of Membrane Biology · doi:10.1007/s00232-024-00307-2 · Cited by 16
Kashyap, D., Varshney, N., Parmar, H. S., & Jha, H. C. (2021) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2021.100023 · Cited by 12
Bala, A., & Panditharadyula, S. S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190705205155 · Cited by 12
Reactive oxygen species and cancer
Kong, H., & Chandel, N. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00030-4 · Cited by 12
Hydrogen peroxide formation by Nox4 limits malignant transformationPreprint
Helfinger, V., von Gall, F. F., Henke, N., Kunze, M. M., Schmid, T., Heidler, J., Wittig, I., Radeke, H. H., Marschall, V., Anderson, K. E., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/177055 · Cited by 12
Jin, B., Xie, L., Zhan, D., Zhou, L., Feng, Z. W., He, J., Qin, J., Zhao, C., Luo, L., & Li, L. (2022) · Development · doi:10.1242/dev.200342 · Cited by 10
Pesticides, cancer, and oxidative stress: an application of machine learning to NHANES data
Liu, Y., Li, K., Li, C., Feng, Z., Cai, Y., Zhang, Y., Hu, Y., Wei, X., Yao, P., Liu, X., et al. (2024) · Environmental Sciences Europe · doi:10.1186/s12302-023-00834-0 · Cited by 11
Yang, Q., Yan, R., Zhang, J., Zhang, T., Kong, Q., Zhang, X., Xia, H., Ye, A., Qiao, X., Kato, K., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165207 · Cited by 11
Nrf2 protein in melanoma progression, as a new means of treatment
Feng, Q., Xu, X., & Zhang, S. (2023) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13137 · Cited by 12
Li, J., Guo, Q., Wei, X., Zhu, Y., Luo, M., & Luo, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1304167 · Cited by 11
Tumour Suppressor Genes with Oncogenic Roles in Lung Cancer
Barros‐Filho, M. C., Guisier, F., Rock, L. D., Becker‐Santos, D. D., Sage, A. P., Marshall, E. A., & Lam, W. L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85017 · Cited by 13
Regulation of NRF2 by Na+/K+-ATPase: implication of tyrosine phosphorylation of Src
Nam, L. B., & Keum, Y. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1735633 · Cited by 11
Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
Fragoulis, A., Schenkel, J., Schröder, N., Brandt, E. F., Weiand, M., Neu, T., Ramadori, P., Caspers, T., Kant, S., Pufe, T., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102453 · Cited by 11
McGivney, G. R., Brockman, Q. R., Borcherding, N. C., Scherer, A., Rauckhorst, A. J., Gutierrez, W. R., Solst, S. R., Heer, C. D., Warrier, A., Floyd, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu2906 · Cited by 10
Buranarom, A., Navasumrit, P., Ngaotepprutaram, T., & Ruchirawat, M. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109580 · Cited by 10
Exploring structural effects in a new class of NRF2 inhibitors
Hou, Z., Lockwood, L. R., Zhang, D., Occhiuto, C. J., Mo, L., Aldrich, K. E., Stoub, H., Gallo, K. A., Liby, K. T., & Odom, A. L. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00211f · Cited by 11
Dexmedetomidine promotes colorectal cancer progression via Piwil2 signaling
Dong, J., Che, J., Wu, Y., Deng, Y., Jiang, X., He, Z., & Zhang, J. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00944-8 · Cited by 10
In vivo and in vitro Models of PM2.5 Induced COPD: Focus on the Role of RTA-408
Niu, Y., Zhang, L., Guo, S., & Wu, S. (2024) · International Journal of COPD · doi:10.2147/copd.s475281 · Cited by 10
Mendonca, P. (2024) · American Journal of Cancer Research · doi:10.62347/anxs3815 · Cited by 10
Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
Fu, S., Ma, J., Cai, C., Tan, J., Deng, X., Shen, H., Zeng, S., Chen, Y., & Han, Y. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03444-1 · Cited by 11
Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24
Sánchez-Ortega, M., Garrido, A., Sanz, L., Torres‐Pérez, R., Hernandez, C., Gutiérrez-Uzquiza, Á., Tsao, M., & Carrera, A. C. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02401-y · Cited by 10
Dai, Y., Chen, H., Pan, Y., & Song, H. (2022) · BioMed Research International · doi:10.1155/2022/9418332 · Cited by 10
Moerland, J. A., Leal, A. S., Lockwood, B., Demireva, E. Y., Xie, H., Krieger-Burke, T., & Liby, K. T. (2023) · Antioxidants · doi:10.3390/antiox12010116 · Cited by 10
Shintyapina, A. B., Андреевич, В. В., Safronova, O. G., & Lyakhovich, V. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176939 · Cited by 10
Park, S., Jang, J., & Moon, E. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1505044 · Cited by 10
Jiménez-Vidal, L., Espitia-Pérez, P., Torres, J. F., Ricardo-Caldera, D., Salcedo-Arteaga, S., Galeano–Páez, C., Pastor–Sierra, K., & Espitia-Pérez, L. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-019-0360-4 · Cited by 10
Dai, B., Augustine, J. J., Kang, Y., Roife, D., Li, X., Deng, J., Tan, L., Rusling, L. A., Weinstein, J. N., Lorenzi, P. L., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03970-8 · Cited by 11
Grigolon, G., Araldi, E., Erni, R., Wu, J. Y., Thomas, C., Fortezza, M. L., Laube, B., Pöhlmann, D., Stoffel, M., Zarse, K., et al. (2022) · RePEc: Research Papers in Economics · doi:10.3929/ethz-b-000524798 · Cited by 12
Nrf2 paradox: Can cancer patients eat broccoli?
Surh, Y. (2021) · Food Frontiers · doi:10.1002/fft2.61 · Cited by 10
Shikimic acid protects against doxorubicin-induced cardiotoxicity in rats
Alwaili, M. A., Abu-Almakarem, A. S., El-Said, K. S., Eid, T. M., Mobasher, M. A., Alsabban, A. H., Alburae, N. A., Banjabi, A. A., & Soliman, M. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-90549-4 · Cited by 9
Redox state associated with antitumor and immunomodulatory peptides in cancer
Cruz‐Gregorio, A., Aranda‐Rivera, A. K., Sciutto, E., Fragoso, G., & Pedraza‐Chaverrí, J. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109414 · Cited by 9
Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment
Ngo, H. K. C., Le, H., & Surh, Y. (2023) · Journal of Cancer Prevention · doi:10.15430/jcp.2023.28.4.131 · Cited by 9
Chang, L., Fan, C., Tseng, W., Chein, H., Hsieh, T.-Y., Chen, J., Hwang, C., & Hua, C. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0107 · Cited by 9
Chen, P., Chi, J., & Boyce, M. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1361501 · Cited by 9
LASS2 mediates Nrf2-driven progestin resistance in endometrial cancer.
Yang, B. J., Hu, M., Fu, Y., Sun, D., Zheng, W., Liao, H., Zhang, Z., & Chen, X. (2021) · PubMed Central · Cited by 9
Li, N., Fan, D., Sun, L., Qian, Y., Zhang, L., Wang, G., Yuan, L., Liu, H., Jiang, Y., & Wang, Y. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.03.014 · Cited by 8
Polimeno, L., Viggiani, M. T., Giorgio, F., Polimeno, L., Fratantonio, D., Domenico, M. D., Boccellino, M., Ballini, A., Topi, S., Leo, A. D., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.01.131 · Cited by 8
Parkhurst, A. N., Wang, S. Z., Findlay, T., Malebranche, K. J., Odabas, A., Alt, J., Maxwell, M. J., Kaur, H., Peer, C. J., Figg, W. D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04868-9 · Cited by 8
Li, Y., Li, G.-H., Sun, L., Li, L., Liu, Y., Kong, D., Wang, S., Ren, D., Wang, X., Lou, H., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7616852 · Cited by 8
The Role of Vitamin D and Sunlight Incidence in Cancer
Câmara, A. B., & Brandão, I. A. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1389557519666190312123212 · Cited by 8
Olazábal-Morán, M., Pérez, E., Esteban-Arranz, A., & Garrido, A. (2025) · Biomolecules · doi:10.3390/biom15091316 · Cited by 7
Role of antioxidants in the treatment of hepatocellular carcinoma: Integrative review
Locatelli, C., Jardim, J. K. B., & Zancanaro, V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.12028 · Cited by 7
Shayeghan, M., Ansari, A. M., Forouzesh, F., & Javidi, M. A. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109357 · Cited by 7
Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: a review
Nair, A. S., Jayan, A. P., Anandu, K. R., Nirmala, S. V., & Pappachen, L. K. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04704-4 · Cited by 7
Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?
Muscarella, L. A., & Fazio, V. M. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.85 · Cited by 7
WIP Modulates Oxidative Stress through NRF2/KEAP1 in Glioblastoma Cells
Escoll, M., Lastra, D., Robledinos-Antón, N., Wandosell, F. G., Antón, I. M., & Cuadrado, A. (2020) · Antioxidants · doi:10.3390/antiox9090773 · Cited by 7
Honma, Y., Miyagawa, K., Hara, Y., Hayashi, T., Kusanaga, M., Ogino, N., Minami, S., Oe, S., Ikeda, M., Hino, K., et al. (2021) · Medical Molecular Morphology · doi:10.1007/s00795-020-00271-5 · Cited by 7
Inflammation-Associated Cytotoxic Agents in Tumorigenesis
Arnhold, J. (2023) · Cancers · doi:10.3390/cancers16010081 · Cited by 7
Ajuwon, O. R., Biteghe, F. A. N., Ndong, J. D. L. C., Davids, L. M., Ajiboye, B. O., Brai, B. I. C., Bamisaye, F. A., Falode, J. A., Odoh, I. M., Adegbite, K., et al. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s457749 · Cited by 9
Cho, H., & Lee, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118485 · Cited by 6
Yang, Q., Deng, H., Xia, H., Xu, M., Pan, G.-T., Mao, J., Tao, S., Yamanaka, K., & An, Y. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1642472 · Cited by 6
The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma
Shukla, A., Khan, M. G. M., Cayarga, A. A., Namvarpour, M., Chowdhury, M. M. H., Lévesque, D., Lucier, J., Boisvert, F., Ramanathan, S., & Ilangumaran, S. (2024) · Cancers · doi:10.3390/cancers16020292 · Cited by 7
You, M., Tian, M., Song, Z., Liu, Z., Yang, B., & Zhang, S. (2024) · Nano Letters · doi:10.1021/acs.nanolett.3c03609 · Cited by 6
Research update for ferroptosis and cholangiocarcinoma
Fu, S., Zhang, Q., & Zhang, C. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104356 · Cited by 7
Santoshrao, J. G., Jamwal, S., Kumar, R., Bisht, E., Krishnakumar, B. H., Katoch, S., & Asrani, R. K. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100674 · Cited by 6
Evaluation of Nrf2, Keap1 and Apoptotic Pathway Genes Expression in Acute Myeloid Leukemia Patients.
Jalali, A., Mahmoudi, S., Harchegani, A. L., Asl, J. M., & Ahmadzadeh, A. (2021) · PubMed Central · doi:10.22037/ijpr.2019.14907.12738 · Cited by 6
Cysteine Metabolism in Cancer Progression and Therapy Resistance
Nin, D. S., Idres, S. B., & Deng, L. (2021) · Springer eBooks · doi:10.1007/978-981-16-0522-2_7 · Cited by 6
Idres, Y. A., Tousch, D., Cazals, G., Lebrun, A., Naceri, S., Bidel, L., & Poucheret, P. (2021) · Antioxidants · doi:10.3390/antiox10101617 · Cited by 6
Tumor Promoting Effects of Sulforaphane on Diethylnitrosamine-Induced Murine Hepatocarcinogenesis
Zheng, J., Kim, D.-H., Fang, X.-Z., Kim, S., Saeidi, S., Kim, S.-J., & Surh, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105397 · Cited by 5
A detailed insight into macrophages' role in shaping lung carcinogenesis
Aktar, T., Modak, S., Majumder, D., & Maiti, D. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122896 · Cited by 6
Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma
Serra, M., Columbano, A., Perra, A., & Kowalik, M. A. (2020) · Cancers · doi:10.3390/cancers12113318 · Cited by 7
Self-citationZakić, T., Jevtic, J., Vukobratovic, M., Djuric, S., Golić, I., Korać, A., Pekovic‐Vaughan, V., Janković, A., & Korać, B. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.07.027 · Cited by 7
Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma
Peng, X., Feng, J., Yang, H., Xia, P., & Pu, F. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101335 · Cited by 6
Molecular and functional characterization of MST2 in grass carp during bacterial infection
Li, Y., Qiu, X., Lu, Z., Zhan, F., Yang, M., Babu, V. S., Li, J., Qin, Z., & Lin, L. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.09.026 · Cited by 5
Xiang, Y., Dai, S., Ding, L., Zhu, X., Su, J., Chen, B., & Wu, M. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105024 · Cited by 5
[Progress of NRF2 Signaling Pathway in Promoting Proliferation of Non-small Cell Lung Cancer].
Fang, Y., Zou, X., Hu, S., & Ji, L. (2022) · PubMed Central · doi:10.3779/j.issn.1009-3419.2022.102.37 · Cited by 5
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
Mattu, S., Zavattari, P., Kowalik, M. A., Serra, M., Sulas, P., Pal, R. R., Puliga, E., Sutti, S., Foglia, B., Parola, M., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.011 · Cited by 5
Self-citationNRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma
Hu, S., Yuan, Y., Yan, R., Xie, H., Cai, R., & Xu, J. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149798 · Cited by 4
Yu, T., Yuanyuan, L. I., Zhu, J., Sun, Y., Li, Z., Liang, L., Zhu, Y., Dong, T., & Nie, F. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.172706 · Cited by 4
Taddei, I., Cirotti, C., Lamballe, F., Castellanet, O., Maina, F., Medici, V., Fierro, F., Corleone, G., Nicola, F. D., Fanciulli, M., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03625-y · Cited by 4
Zhang, L., Liu, F., & Li, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1764594 · Cited by 4
Ferroptosis in cancer: integrating multi-omics, AI-driven biomarkers, and translational challenges
Taki, A. G., Shareef, A., Arora, V., Oweis, R. J., Jyothi, S. R., Singh, U., Sahoo, S., Chauhan, A. S., Alimova, F., Sameer, H. N., et al. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121131 · Cited by 5
Song, C., Kim, N., Nam, R. H., Choi, S. I., Jang, J. Y., Kim, E. H., Ha, S., Shin, E., Choi, H., Kim, K., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.35225 · Cited by 4
Insight into Nrf2: a bibliometric and visual analysis from 2000 to 2022
Ma, Y., Wang, Z., & Hu, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1266680 · Cited by 4
Deng, J., Li, N., Hao, L., Li, S., Nie, A., Zhang, J., & Hu, X. (2024) · PeerJ · doi:10.7717/peerj.17692 · Cited by 4
Eryılmaz, I. E., Egelí, Ü., & Çeçener, G. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13694 · Cited by 4
Metadata
- Authors
- Menegon, S., Columbano, A., & Giordano, S.
- Affiliations
- Candiolo Cancer Institute (IT)
- University of Cagliari (IT)
- Corresponding author
- Menegon, Silvia
- Columbano, Amedeo
- Giordano, Silvia
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 22
- Issue
- 7
- Pages
- 578-593
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2417535489
- Cited by
- 633
- References
- 114
- Citations by year
- 2026: 28 · 2025: 43 · 2024: 64 · 2023: 60 · 2022: 74 · 2021: 75 · 2020: 69 · 2019: 72 · 2018: 73 · 2017: 57 · 2016: 16
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, cc-by-nc-nd)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro (15464, 15279, IG-15279)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- Nrf2, Nrf2 signaling, oncogenic function, tumor suppressor, oxidative stress, chemoresistance, radioresistance (biology), Nrf2 inhibitors, therapeutic target, cancer
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Antineoplastic Agents, Humans, Mutation, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Oxidative Stress, MicroRNAs, Epigenesis, Genetic, NF-E2-Related Factor 2, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review